ADO 0.00% 2.1¢ anteotech ltd

Ann: Investor Webinar Invitation, page-167

  1. 11 Posts.
    lightbulb Created with Sketch. 1
    There is mention of TGA submission for COVID-19 RAT in the Quarterly Business Update issued today.

    3. Internal TGA Submission Review – In Q2 FY2023, AnteoTech will review the Therapeutic Goods
    Administration (TGA) requirements, the Australian RAT market conditions, and the COVID-19 outlook
    to determine AnteoTech’s position in relation to a new TGA submission.
 
watchlist Created with Sketch. Add ADO (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.